NEW YORK ( TheStreet) -TheStreet Ratings' stock model upgraded LSB Financial Corp ( LSBI) to 'Buy' from 'Hold'. Net income at this $23.9 million market cap, Indiana bank flipped to a profit of $0.6 million compared to a loss of $0.2 million in the prior fourth quarter.

TheStreet Ratings released rating changes on 11 U.S. common stocks for March 29, 2011. In total, seven stocks were upgraded and four stocks were downgraded by our stock model.

In the fourth quarter, LSB Financial reported $5.7 million in revenue, an increase of 0.3% compared to the year earlier quarter. Learn more about LSB Financial: Company Profile, Income Statement, Balance Sheet, Stock Ratios, Analyst Ratings.

$213 million market cap, biopharmaceutical company, Synta Pharmaceuticals Corp ( SNTA) was downgraded to 'Sell' from 'Hold'. In fourth quarter results, Synta Pharmaceuticals' net loss expanded by 25.4% to a loss of $8.8 million compared to the year earlier quarter. Over the same time period, revenue decreased by 13.7% to $4.0 million. Learn more about Synta Pharmaceuticals: Company Profile, Income Statement, Balance Sheet, Stock Ratios, Analyst Ratings.

-- Reported by Kevin Baker in Jupiter, FL.

For additional Investment Research check out our Ratings Research Center.
Kevin Baker became the senior financial analyst for TheStreet Ratings upon the August 2006 acquisition of Weiss Ratings by TheStreet.com, covering equity and mutual fund ratings. He joined the Weiss Group in 1997 as a banking and brokerage analyst. In 1999, he created the Weiss Group's first ratings to gauge the level of risk in U.S. equities. Baker received a B.S. degree in management from Rensselaer Polytechnic Institute and an M.B.A. with a finance specialization from Nova Southeastern University.

If you liked this article you might like

Why LSB Financial (LSBI) Stock Is Skyrocketing This Afternoon